1st Quarter - Report

TCH GROUP, LLC for SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC )

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Issues related to importation/reimportation of prescription drugs and the Labor HHS-Education Appropriations Act.

Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE

Health Issues HCR

HR 3610 "Food and Drug Import Safety Act of 2007"; S. 242, HR 380, "Pharmaceutical Market Access and Drug Safety Act of 2007", HR 2638, "Department of Homeland Security Appropriations Act, 2008"; H. AMDY 734 to HR 3161 and S1859 "agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2008" (provisions related to imporation of prescription pharmaceuticals, safety inspections of such products, and the adequacy to protect the American public from counterfeit, adultered, and sub-potent products. HR2606 and S1376 "340B Program Improvement and Integrity Act of 2007"; HR380 "Pharmaceutical Market Access and Drug Safety Act of 2007" (provisions related to proposed changes to the 340B federal drug pricing program).

Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE

Bills named: H.R. 3161 (110th), H.R. 2606 (110th), H.R. 3610 (110th), S. 242 (110th), H.R. 2638 (110th), H.R. 380 (110th)

Medicare/Medicaid MMM

Issues and provisions related to the closure of the Medicare Part D donut hole and other improvements for beneficiaries of the Medicare program, and the Medicaid drug rebate, including such provisions in HR3162 "The Children's Health and Medicare Protection Act of 2007 and S1607, "The Children's Health Insurance Program Reauthorization Act of 2007." Coding and reimbursement of coverage issues for Medicare Part B products and Medicare Part D services, preventative health screenings and assessments, and obesity drugs; issues relatd to DVT prevention and awareness, including draft legislation "Deep Vein Thrombosis Prevention Act of 2007"; issues related to osteoporosis prevention, awareness, and screening.

Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE

Bills named: H.R. 3162 (110th)

Medical/Disease Research/Clinical Labs MED

Issues related to follow-on biologics, drug safety, importation/reimportation of prescription drugs, drug advertising, and the Citizen's Petition process, including such provisions in S1082 "The Food and Drug Administration Revitalization Act" and HR3580. "The Food and Drug ADministration Amendment Act of 2007", and HR3610 "Fodd and Drug Safety Act of 2007"; HR1038 "Access to Life-Saving Medicine Act" and S1695 "Biologics Price Competition and Innovation Act of 2007" All provisions.

Foreign entity interest: sanofi-aventis U.S. inc. is an international company with headquarters in Paris, France.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE

Bills named: H.R. 3580 (110th), H.R. 1038 (110th), H.R. 3610 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.